Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Tvardi Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TVRD alerts

About Derek Chalmers

Derek Chalmers is recorded as CEO at Tvardi Therapeutics, Inc. (TVRD). The newest filing on record that lists Derek Chalmers as CEO at Tvardi Therapeutics, Inc. (TVRD) is dated April 22, 2022. The proxy statement of Tvardi Therapeutics, Inc. reports total compensation of $10,196,785 for Derek Chalmers in fiscal 2021, including a base salary of $570,062. Disclosed compensation is on record for 4 fiscal years. Tvardi Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tvardi Therapeutics, Inc. includes Imran Alibhai (CEO and Board Member), Imran Alibhai, Ph.D. (CEO and Board Member), Sujal Shah (Chairman and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Tvardi Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Tvardi Therapeutics, Inc. (TVRD) $570,062 $10,196,785
2020 Tvardi Therapeutics, Inc. (TVRD) $576,800 $2,913,609
2019 Tvardi Therapeutics, Inc. (TVRD) $560,000 $3,433,617
2018 Tvardi Therapeutics, Inc. (TVRD) $542,100 $2,789,046

Recent activity

No call appearances or filed executive changes recorded yet.